Invesco Proposes Shareholder-Friendly Bye-Laws Amendment and Details 2025 Executive Compensation
Summary
Invesco Ltd. filed a preliminary proxy statement outlining proposals for its 2026 Annual General Meeting, including a significant amendment to its Bye-Laws to allow shareholders to remove directors with or without cause, alongside detailed 2025 executive compensation.
Key Events
-
Proposed Bye-Laws Amendment
Shareholders will vote on amending the company's Bye-Laws to permit director removal with or without cause, enhancing shareholder power and board accountability.
-
2025 Executive Compensation Details
CEO Andrew R. Schlossberg's total annual compensation for 2025 was $18.5 million, with 'compensation actually paid' reported as $36.27 million. Other Named Executive Officers also received substantial compensation.
-
Strong 2025 Financial Performance
The company reported a 6% organic growth rate, $81.2 billion in net long-term inflows, and a 19% increase in adjusted diluted EPS for 2025, which underpinned executive incentive payouts.
-
2026 Compensation Adjustments
The Compensation Committee approved increases to the CEO's base salary to $1 million and annual incentive target to $15.5 million for 2026, with similar adjustments for other NEOs.
Analysis
The proposed amendment to Invesco's Bye-Laws, allowing shareholders to remove directors with or without cause, represents a material enhancement of corporate governance and shareholder rights. This move aligns the company with prevalent best practices and increases board accountability. The filing also provides comprehensive details on 2025 executive compensation, highlighting a significant pay package for CEO Andrew R. Schlossberg, which is presented as aligned with the company's strong financial and operational performance in 2025. While the compensation figures are substantial, the company emphasizes its pay-for-performance philosophy and high shareholder support for executive compensation in the prior year. Investors should monitor the outcome of the Bye-Laws vote as it signifies a notable shift in governance structure.
At the time of this filing, IVZ was trading at $23.03 on NYSE in the Finance sector, with a market capitalization of approximately $10.2B. The 52-week trading range was $11.60 to $29.61. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.